VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Pharmaceutical
The shares of German life sciences group Merck KGaA rose 1.2% to 93.48 euros in early trading, when it released third-quarter 2017 financial results. 9 November 2017
Biotechnology
Better-than-expected third-quarter financial results at Regeneron Pharmaceuticals sent its share price up by 1%, to $408.75, after four hours of trading on Wednesday. 8 November 2017
Pharmaceutical
Danish CNS specialist saw its shares drop 6.07% to 352.00 Danish kroner this morning, as it posted a strong set of financials for the first nine months of 2017. 8 November 2017
Pharmaceutical
Canada’s Valeant Pharmaceuticals International, which has been shedding former acquisitions like confetti in order to reduce its debt burden, today reported better-than-expected third-quarter 2017 financials. 7 November 2017
Pharmaceutical
The sales figures and stock value of Catalan drugmaker Almirall have taken a pummeling this year, and the latest results showed that the third quarter had been another tough one for Spain’s biggest pharma company. 6 November 2017
Generics
Netherlands-incorporated generics major Mylan saw its shares rise 0.9% to $36.40 in late-morning trading, have hit a $36.92 pre-market after posting third-quarter 2017 financials that came in below analysts’ forecasts. 6 November 2017
Generics
The first job of Kåre Schultz, the new president chief executive of Teva Pharmaceutical Industries, will be to pick the company off the floor after another disastrous set of financial results and subsequent stock market pounding. 2 November 2017
Pharmaceutical
Allergan closed more than 4% up on Wednesday at $184.58 after presenting its third-quarter results. 2 November 2017
Pharmaceutical
French pharma major Sanofi today posted third-quarter 2017 financials, which came in slightly below expectations and showing that total sales rose 4.7% to 9.05 billion euros ($10.54 billion). 2 November 2017
Pharmaceutical
Danish diabetes giant Novo Nordisk saw its shares dip this morning, after the company warned that draft legislation in some US states to make pricing more transparent could impact business in its largest market, and forecast only modest growth for the full years 2017 and 2018. 1 November 2017
Pharmaceutical
Pfizer beat Wall Street earnings estimates with its third-quarter results, but no-one was getting too carried away at the US pharma giant or among its investors. 31 October 2017
Pharmaceutical
Shares of USA-based AbbVie (NYSE: ABBV) closed up 2.33% at $91.93 on Friday, having hit a day high of $94.97, after the company post third-quarter 2017 financial results. 28 October 2017
Biotechnology
Ireland-headquartered Shire saw its shares close up 1.5% at 3,576.57 pence on Friday, after the company posted third-quarter 2017 earnings that beat expectations. 28 October 2017
Pharmaceutical
The share price of US pharma giant Merck & Co was down 5% by lunchtime on Friday at $58.74. 27 October 2017
Biotechnology
In two hours of trading on Thursday, nearly $14 billion was wiped off the market value of Celgene as the US biotech’s share price plummeted by 18% to $98.13. 26 October 2017
Pharmaceutical
Bristol-Myers Squibb has posted profits from the latest quarter that missed analysts’ expectations. 26 October 2017
Pharmaceutical
Germany’s Bayer saw its shares fall as much as 3.5% to 110.85 euros this morning, after the company released its third-quarter 2017 financial results, which showed that sales were dragged down by its consumer health business. 26 October 2017
Biotechnology
Third quarter financial results from Amgen show a slight fall in revenue, coming in around analysts’ expectations at $5.8 billion. 26 October 2017
Pharmaceutical
Despite reporting significant sales growth for the third-quarter of 2017, French biopharma firm Ipsen saw its shares drop 6.43% to 105.50 euros in morning trading. 26 October 2017
Pharmaceutical
There did not appear too much to worry investors in the third-quarter financial results of the UK’s biggest pharma company, GlaxoSmithKline, as they were presented on Tuesday. 26 October 2017
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze